Next-Generation PCR ONLINE: Applications of dPCR in liquid biopsy and cancer monitoring
Front Line Genomics
3/18/21, 7:00 PM
Europe/Berlin CET+2
Description
dPCR is particularly helpful in helping to quantify nucleic acids at a low frequency. With isolating ctDNA from a simple blood draw being likened to finding a needle in a haystack, improving our ability to detect these biomarkers in blood can improve the way we diagnose and monitor cancers forever.
This webinar will focus on the applications of dPCR in liquid biopsies, as well as future developments for these to be used routinely.
Ensuring the reliability of ctDNA results for clinical applications - Valerie Taly, Group Leader, INSERM
Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors – Ed Schuuring, Professor of Molecular Oncological Pathology, University Medical Centre Groningen
The implementation of dPCR in liquid biopsy and its considerations - Daniel Lofgren, Market Development Manager, Digital PCR, EMEA, QIAGEN
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Ensuring the reliability of ctDNA results for clinical applications, Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors, The implementation of dPCR in liquid biopsy and its considerations
Inglês
Speakers
Valerie Taly, Ed Schuuring, Daniel Lofgren
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.